NM_004621.6:c.2485-138C>T
Variant names:
Variant summary
Our verdict is Benign. The variant received -20 ACMG points: 0P and 20B. BP4_StrongBP6_Very_StrongBA1
The NM_004621.6(TRPC6):c.2485-138C>T variant causes a intron change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.243 in 696,594 control chromosomes in the GnomAD database, including 24,924 homozygotes. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Benign (★★).
Frequency
Genomes: 𝑓 0.31 ( 9617 hom., cov: 32)
Exomes 𝑓: 0.22 ( 15307 hom. )
Consequence
TRPC6
NM_004621.6 intron
NM_004621.6 intron
Scores
2
Clinical Significance
Conservation
PhyloP100: -2.50
Publications
2 publications found
Genes affected
TRPC6 (HGNC:12338): (transient receptor potential cation channel subfamily C member 6) The protein encoded by this gene forms a receptor-activated calcium channel in the cell membrane. The channel is activated by diacylglycerol and is thought to be under the control of a phosphatidylinositol second messenger system. Activation of this channel occurs independently of protein kinase C and is not triggered by low levels of intracellular calcium. Defects in this gene are a cause of focal segmental glomerulosclerosis 2 (FSGS2). [provided by RefSeq, Mar 2009]
TRPC6 Gene-Disease associations (from GenCC):
- focal segmental glomerulosclerosis 2Inheritance: AD Classification: STRONG Submitted by: Labcorp Genetics (formerly Invitae), Ambry Genetics
- familial idiopathic steroid-resistant nephrotic syndromeInheritance: AD Classification: SUPPORTIVE Submitted by: Orphanet
Genome browser will be placed here
ACMG classification
Classification was made for transcript
Our verdict: Benign. The variant received -20 ACMG points.
BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.99).
BP6
Variant 11-101455239-G-A is Benign according to our data. Variant chr11-101455239-G-A is described in ClinVar as Benign. ClinVar VariationId is 1234385.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars.
BA1
GnomAd4 highest subpopulation (AFR) allele frequency at 95% confidence interval = 0.575 is higher than 0.05.
Transcripts
RefSeq
Ensembl
Frequencies
GnomAD3 genomes AF: 0.311 AC: 47310AN: 151936Hom.: 9584 Cov.: 32 show subpopulations
GnomAD3 genomes
AF:
AC:
47310
AN:
151936
Hom.:
Cov.:
32
Gnomad AFR
AF:
Gnomad AMI
AF:
Gnomad AMR
AF:
Gnomad ASJ
AF:
Gnomad EAS
AF:
Gnomad SAS
AF:
Gnomad FIN
AF:
Gnomad MID
AF:
Gnomad NFE
AF:
Gnomad OTH
AF:
GnomAD4 exome AF: 0.224 AC: 121871AN: 544540Hom.: 15307 Cov.: 7 AF XY: 0.224 AC XY: 65111AN XY: 290696 show subpopulations
GnomAD4 exome
AF:
AC:
121871
AN:
544540
Hom.:
Cov.:
7
AF XY:
AC XY:
65111
AN XY:
290696
show subpopulations
African (AFR)
AF:
AC:
8023
AN:
13744
American (AMR)
AF:
AC:
3843
AN:
25716
Ashkenazi Jewish (ASJ)
AF:
AC:
4200
AN:
16082
East Asian (EAS)
AF:
AC:
3879
AN:
30232
South Asian (SAS)
AF:
AC:
12614
AN:
52334
European-Finnish (FIN)
AF:
AC:
5451
AN:
34356
Middle Eastern (MID)
AF:
AC:
838
AN:
2438
European-Non Finnish (NFE)
AF:
AC:
76013
AN:
340934
Other (OTH)
AF:
AC:
7010
AN:
28704
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.496
Heterozygous variant carriers
0
4263
8527
12790
17054
21317
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance
Age Distribution
Exome Het
Exome Hom
Variant carriers
0
930
1860
2790
3720
4650
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome AF: 0.312 AC: 47399AN: 152054Hom.: 9617 Cov.: 32 AF XY: 0.304 AC XY: 22583AN XY: 74326 show subpopulations
GnomAD4 genome
AF:
AC:
47399
AN:
152054
Hom.:
Cov.:
32
AF XY:
AC XY:
22583
AN XY:
74326
show subpopulations
African (AFR)
AF:
AC:
24082
AN:
41440
American (AMR)
AF:
AC:
3007
AN:
15266
Ashkenazi Jewish (ASJ)
AF:
AC:
900
AN:
3470
East Asian (EAS)
AF:
AC:
341
AN:
5180
South Asian (SAS)
AF:
AC:
1098
AN:
4832
European-Finnish (FIN)
AF:
AC:
1587
AN:
10566
Middle Eastern (MID)
AF:
AC:
110
AN:
294
European-Non Finnish (NFE)
AF:
AC:
15449
AN:
67988
Other (OTH)
AF:
AC:
650
AN:
2110
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.504
Heterozygous variant carriers
0
1461
2922
4384
5845
7306
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance
Age Distribution
Genome Het
Genome Hom
Variant carriers
0
440
880
1320
1760
2200
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
Hom.:
Bravo
AF:
Asia WGS
AF:
AC:
658
AN:
3478
ClinVar
Significance: Benign
Submissions summary: Benign:2
Revision: criteria provided, multiple submitters, no conflicts
LINK: link
Submissions by phenotype
not provided Benign:2
-
Breakthrough Genomics, Breakthrough Genomics
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:not provided
- -
Aug 20, 2019
GeneDx
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing
- -
Computational scores
Source:
Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
DANN
Benign
PhyloP100
Splicing
Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
Details are displayed if max score is > 0.2
Find out detailed SpliceAI scores and Pangolin per-transcript scores at
Publications
You must be logged in to view publications. This limit was set because tens of millions (!) of queries from AI bots are generated daily.